SDGR Company Profile and Key Details

Q: Who are the executives of SDGR?

Mr. Kenneth Patrick LortonExecutive Vice President & Chief Technology OfficerDr. Karen Akinsanya Ph.D.Pres of R&D TherapeuticsDr. Ramy Farid Ph.D.Chief Executive Officer, Pres & DirectorDr. Richard A. Friesner Ph.D.Co-Founder, Scientific Advisory Chairman and DirectorDr. Geoffrey Craig Porges MBBSExecutive Vice President & Chief Financial OfficerMs. Jaren Irene MaddenSenior Vice President of Investor Relations & Corporation CommunicationsProf. William Goddard IIICo-Founder & Scientific AdvisorMs. Jenny HermanSenior Vice President of Fin. & Corporation ControllerMr. Shane BraunerExecutive Vice President & Chief Information OfficerDr. Robert Lorne Abel Ph.D.Executive Vice President of Science, Chief Computational Scientist and Head of Modeling R&DMs. Yvonne Tran Esq.Chief Legal & People Officer

NASDAQ : SDGR

Schrödinger

$15.04

-0.19-1.25%

At Close 4:00 PM

61.23

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Schrödinger, Inc. (SDGR) stock declined over -1.25%, trading at $15.04 on NASDAQ, down from the previous close of $15.23. The stock opened at $15.28, fluctuating between $14.92 and $15.71 in the recent session.

Stock Snapshot

15.23

Prev. Close

1.12B

Market Cap

14.924

Day Low

-10.74

P/E Ratio

-1.4

EPS (TTM)

-2.08

Cash Flow per Share

15.28

Open

74.72M

Number of Shares

15.71

Day High

78.56%

Free Float in %

7.6

Book Value

955.29K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 23, 2026	14.98	15.71	14.92	15.04	1.16M
Jun 22, 2026	15.71	15.99	15.09	15.23	987.23K
Jun 18, 2026	15.78	16.04	15.39	15.76	1.56M
Jun 17, 2026	14.89	16.30	14.75	15.53	1.48M
Jun 16, 2026	14.69	15.22	14.52	14.93	1.19M
Jun 15, 2026	14.77	15.08	14.46	14.60	1.05M
Jun 12, 2026	14.71	14.88	14.20	14.45	863.45K
Jun 11, 2026	14.19	14.66	13.90	14.60	919.18K
Jun 10, 2026	14.37	14.67	14.03	14.15	961.78K
Jun 09, 2026	14.23	15.04	14.09	14.52	927.97K
Jun 08, 2026	14.52	14.73	14.28	14.40	865.74K
Jun 05, 2026	15.85	15.85	14.23	14.38	1.35M
Jun 04, 2026	15.01	16.47	14.85	15.85	2.47M
Jun 03, 2026	14.66	14.99	14.41	14.93	1.57M
Jun 01, 2026	15.23	16.09	14.81	15.80	2.28M
May 29, 2026	14.16	15.44	13.94	15.20	2.34M
May 28, 2026	13.18	14.23	13.05	14.16	1.23M
May 27, 2026	13.07	13.83	13.07	13.24	1.02M
May 26, 2026	13.23	13.49	13.09	13.15	1.02M
May 22, 2026	13.27	13.65	13.12	13.30	1.32M

Contact Details

New York City, NY 10036

United States

https://www.schrodinger.com 212 295 5800

About Company

Schrödinger, Inc., along with its affiliated entities, specializes in developing and deploying a sophisticated, physics-based software platform designed to accelerate the discovery of novel molecules. This technology finds application in both pharmaceutical development and various materials science endeavors. The company's operations are divided into two primary segments: Software and Drug Discovery. Within its Software division, Schrödinger focuses on marketing and licensing its specialized software. This software primarily serves drug discovery efforts within the life sciences industry, but also caters to clients in materials science sectors. Conversely, the Drug Discovery segment is dedicated to cultivating a portfolio of both preclinical and clinical programs. These initiatives are pursued both through internal research and development and via strategic collaborations. Schrödinger's global clientele spans biopharmaceutical companies, industrial enterprises, academic institutions, and government research laboratories worldwide. Founded in 1990, the company maintains its headquarters in New York, New York.

Stock Peers

BTSGU

-1.26-0.57%

BrightSpring Health Services, Inc. Tangible Equity Unit$221.25 NUTX

-2.94-1.96%

Nutex Health, Inc.$147.23 HQY

0.31+0.37%

HealthEquity, Inc.$84.92 BTSG

-0.36-0.54%

BrightSpring Health Services, Inc. Common Stock$66.84 GEHC

3.08+5.08%

GE HealthCare Technologies Inc.$63.72 WGS

2.66+4.80%

GeneDx Holdings Corp.$58.08 TEM

0.76+1.59%

Tempus AI, Inc.$48.61 OMCL

-0.27-0.70%

Omnicell, Inc.$38.41 HTFL

0.64+1.89%

Heartflow, Inc. Common Stock$34.48 TXG

-1.07-3.25%

10x Genomics, Inc.$31.87

Company Overview

Schrödinger, Inc. (NASDAQ:SDGR) closed at $15.04 USD, losing -$0.19 (-1.25%) from the previous close of $15.23. The stock is currently mid-range between its 52-week high and low $10.95 and $23.75. With a market capitalization of about $1.12 billion, Schrödinger, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.66). Key stats such as the average daily volume over the past year has been around 1.35 million shares, in line with its 52-week average. Headquartered in New York, NY, Schrödinger, Inc. operates in the Healthcare sector and the Software - Application industry. Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 1.51%, SMA50 -18.23%, SMA200 -33.22%). The stock’s 14-day RSI is 44.33 (neutral), while the ATR of 0.76 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -53.82% below its high and over 14.85% above its low. Average 10-day trading volume of 1.24 million shares is in line with the 3-month average of 1.34 million, indicating normal recent market interest.

Valuation Metrics

Schrödinger, Inc. trades at a P/E ratio of -10.64, slightly below the S&P 500 average, with a price-to-sales ratio of 4.4 and a price-to-book ratio of 3.54 trading at moderately above to book value. The P/FCF stands at -7.56, also above market averages.

Dividend & Fair Value

Schrödinger, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$23.32. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Schrödinger, Inc. generated EPS of -$2.40 over the past year. Five-year average earnings growth is -45.98%. The latest quarter delivered EPS of -$0.81. The next quarter is forecast at -$0.47. Next year's EPS is expected at -$412.21. Analyst sentiment is neutral. Analyst rating data shows there are 5 Strong Buy ratings, 2 Buy ratings, 6 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $33.00 to $13.00. The high target offers 119.41% upside. The low target suggests -13.56% downside. The mean target is $22.62. This offers 50.4% upside. Schrödinger, Inc. earnings surprise history is a mixed track record. The quarter that ended May 05, 2026, missed forecasts by 44.64%. The prior quarter beat by -438.46%. Over the last six quarters, Apple has recorded several small beats. These include 57.14% in February 26, 2025.

Shareholding & Insider Activity

Schrödinger, Inc. has 64.44 million shares outstanding. The public float is 57.82 million shares, elevated short interest at 23.13% of float. This equals 9.34 million shares. The short ratio is 9.36 days. Institutional investors hold 100.88% of the float. Insiders own 2.91%. SHAW DAVID E holds 6.10 million shares, Farid Ramy has 330.82 thousand shares and Lorton Kenneth Patrick has 89.24 thousand shares. Over the past six months, insider transactions show net selling. They sold 102.18 thousand shares across 15 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Schrödinger generated $216.67M in revenue, or $2.89 per share. Gross margin was 64.66%, operating margin -81.90%, and net profit margin 18.79%. Returns are modest, with ROA at 5.07% and ROE at 7.42%.
On valuation metrics, Schrödinger trades at a P/E of -10.64, P/S of 4.40 and P/B of 3.54. The current ratio is 2.74 and quick ratio is 2.74. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 30.70 days. Debt-to-equity is 0.34, supported by a cash flow-to-debt ratio of -1.36.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Schrödinger posted revenue of $216.67M, down slightly from $180.96M in the prior quarter. Gross profit was $140.11M (margin 64.66%). Operating income was - $177.45M (margin -81.9%). Net income was$40.72M (EPS $0.57).
The company ended the quarter with $468.75M in cash and short-term investments, a total debt of $127.88M, and net debt of - $33.18M. Total assets were $802.96M, with equity of $548.56M. Financials further reflected stability, with operating cash flow of $10.48M, free cash flow of - $2.92M, and capital expenditures of - $13.40M.

Price Forecast & Outlook

Our AI price prediction model suggests that Schrödinger, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.51%, with price expected at $16.17 by July 06, 2026, within a range of $15.34 to $17.00 3-Month Outlook: Projected rise of 26.33%, reaching $19.00 by September 18, 2026, with a range of $17.26 to $20.13. 1-Year Outlook: Projected loss of -64.76%, with price at $5.30 by June 22, 2027, within a range of $3.14 to $7.45.

Key Takeaways

Schrödinger, Inc. (NASDAQ:SDGR) shares are flat -8.72% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Schrödinger, Inc. trading at a premium to the broader market with a P/E of -10.64. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $43.21, suggesting 187.3% upside. Our AI forecast model points to short-term strength (7.51% over two weeks), a medium-term rise (26.33% over three months), and a longer-term loss (-64.76% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Schrödinger, Inc. (SDGR) stock price?

Schrödinger, Inc. (NASDAQ: SDGR) stock price is $15.04 in the last trading session. During the trading session, SDGR stock reached the peak price of $15.71 while $14.92 was the lowest point it dropped to. The percentage change in SDGR stock occurred in the recent session was -1.25% while the dollar amount for the price change in SDGR stock was - $0.19.

SDGR's industry and sector of operation?

The NASDAQ listed SDGR is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Schrödinger, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SDGR?

Mr. Kenneth Patrick Lorton
Executive Vice President & Chief Technology Officer
Dr. Karen Akinsanya Ph.D.
Pres of R&D Therapeutics
Dr. Ramy Farid Ph.D.
Chief Executive Officer, Pres & Director
Dr. Richard A. Friesner Ph.D.
Co-Founder, Scientific Advisory Chairman and Director
Dr. Geoffrey Craig Porges MBBS
Executive Vice President & Chief Financial Officer
Ms. Jaren Irene Madden
Senior Vice President of Investor Relations & Corporation Communications
Prof. William Goddard III
Co-Founder & Scientific Advisor
Ms. Jenny Herman
Senior Vice President of Fin. & Corporation Controller
Mr. Shane Brauner
Executive Vice President & Chief Information Officer
Dr. Robert Lorne Abel Ph.D.
Executive Vice President of Science, Chief Computational Scientist and Head of Modeling R&D
Ms. Yvonne Tran Esq.
Chief Legal & People Officer

How SDGR did perform over past 52-week?

SDGR's closing price is 37.41% higher than its 52-week low of $10.95 where as its distance from 52-week high of $23.75 is -36.67%.

How many employees does SDGR have?

Number of SDGR employees currently stands at 891.

Link for SDGR official website?

Official Website of SDGR is: https://www.schrodinger.com

How do I contact SDGR?

SDGR could be contacted at phone 212 295 5800 and can also be accessed through its website. SDGR operates from 1540 Broadway, New York City, NY 10036, United States.

How many shares of SDGR are traded daily?

SDGR stock volume for the day was 955.29K shares. The average number of SDGR shares traded daily for last 3 months was 1.35M.

What is the market cap of SDGR currently?

The market value of SDGR currently stands at $1.12B with its latest stock price at $15.04 and 74.72M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	891
Beta	1.64
Sales or Revenue	$216.67M
5Y Sales Change%	1.195%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

SDGR Company Profile and Key Details

Schrödinger

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook